Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dare Bioscience Inc (DARE)

Dare Bioscience Inc (DARE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 26,912
  • Shares Outstanding, K 26,646
  • Annual Sales, $ 0 K
  • Annual Income, $ -14,260 K
  • 60-Month Beta 1.82
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.14
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.18
  • Prior Year -0.29
  • Growth Rate Est. (year over year) +51.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.9100 +67.03%
on 06/29/20
1.7700 -14.12%
on 07/14/20
+0.5200 (+52.00%)
since 06/12/20
3-Month
0.9100 +67.03%
on 06/29/20
1.7700 -14.12%
on 07/14/20
+0.4985 (+48.80%)
since 04/14/20
52-Week
0.6902 +120.23%
on 11/14/19
2.2200 -31.53%
on 01/13/20
+0.7200 (+90.00%)
since 07/12/19

Most Recent Stories

More News
Dare Bioscience Announces Publication of a Peer-Reviewed Journal Article Supporting the Use of the Postcoital Test Study as a Predictor of Contraceptive Effectiveness by Biology of Reproduction

Includes positive clinical findings from a postcoital test (PCT) human clinical study of Ovaprene(R), an investigational hormone-free, monthly contraceptive

DARE : 1.5200 (+50.50%)
Dare Bioscience Announces Initiation of Pivotal Phase 3 Study of DARE-BV1 in Patients with Bacterial Vaginosis

Dare Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced the initiation of the DARE-BVFREE study, a multi-center, double-blind, placebo-controlled Phase 3 clinical study...

DARE : 1.5200 (+50.50%)
Dare Bioscience Announces Receipt of $1.5 Million Under the Current Grant Supplement Award for Continued Development of User-Controlled Long Acting Reversible Contraceptive

Dare Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced the receipt by its wholly owned subsidiary of $1.5 million in additional grant funding from the Bill & Melinda...

DARE : 1.5200 (+50.50%)
Dare Bioscience Announces Participation in BIO Digital 2020

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that the company will participate in the BIO International Convention, which will be held in a new, virtual...

DARE : 1.5200 (+50.50%)
Dare Bioscience Reports First Quarter 2020 Financial Results and Provides Company Update

Conference Call Today at 4:30 p.m. Eastern Time

DARE : 1.5200 (+50.50%)
Dare Bioscience and Health Decisions Form Strategic Partnership to Accelerate the Development of Dare's Novel Pipeline of Women's Health Programs

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, and Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women's health clinical research...

DARE : 1.5200 (+50.50%)
Dare Bioscience to Host First Quarter 2020 Financial Results and Company Update Conference Call and Webcast on May 14, 2020

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, May 14, 2020, to...

DARE : 1.5200 (+50.50%)
Dare Bioscience CEO to Participate in Maxim Group's Infectious Disease Virtual Conference

Dare Bioscience, Inc.(NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, President and Chief Executive Officer, will participate in a panel discussion...

DARE : 1.5200 (+50.50%)
Anika Names Cheryl R. Blanchard, Ph.D., as President and Chief Executive Officer

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform, today...

STIM : 1.9800 (+5.88%)
DARE : 1.5200 (+50.50%)
ANIK : 36.33 (+2.74%)
Dare Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC

Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced it entered into a $15 million common stock purchase agreement and registration rights agreement with Lincoln...

LPBC : 5.7000 (unch)
DARE : 1.5200 (+50.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade DARE with:

Business Summary

Dare Bioscience, Inc. is a healthcare company. It involved in the development and commercialization of products in women's reproductive health. Dare Bioscience, Inc., formerly known as Cerulean Pharma Inc., is based in SAN DIEGO.

See More

Key Turning Points

2nd Resistance Point 2.1667
1st Resistance Point 1.8433
Last Price 1.5200
1st Support Level 1.1233
2nd Support Level 0.7267

See More

52-Week High 2.2200
Fibonacci 61.8% 1.6356
Last Price 1.5200
Fibonacci 50% 1.4551
Fibonacci 38.2% 1.2746
52-Week Low 0.6902

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar